10x Genomics
Business Services · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
6230 Stoneridge Mall Rd, Pleasanton, Cal...Phone Number
(925) 401-7300Website
www.10xgenomics.comRevenue
$616.9 MillionStock Symbol
TXGIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
6
2
2
3
3
2
About 10x Genomics
Headquartered in Pleasanton, California, 10x Genomics is an American biotechnology company. The company designs and manufactures gene sequencing technology used in scientific research.Explore more
10x Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 10x Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once 10x Genomics has new funding data
Congratulate Masked Content for being promoted to Masked Content at 10x Genomics
Click to see if 10x Genomics had a recent Job posting/layoffs
Earning: See what the market has to say on 10x Genomics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when 10x Genomics launches new products
10x Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if 10x Genomics is spiking on competitors!
Check if 10x Genomics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined 10x Genomics as Masked Content
Find more new buyers
Compare Similar Companies to 10x Genomics
Compare insights from companies similar to 10x Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
10x Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
10x Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about 10x Genomics.
10x Genomics financials insights
Gather financial insights about 10x Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$22.5M
2015
Series B
$55.5M
2016
Series C
$55M
2018
Series D
$50M
Other Financing Round
$75M
2019
Stock Offering
$390M
10x Genomics Tech Stack
A closer look at the technologies used by 10x Genomics
Most Recent Scoops
Product Launch
10x Genomics has announced the launch of Atera, a spatial biology platform that delivers advances in throughput, flexibility, and sensitivity, enabling spatial whole transcriptome profiling with single-cell sensitivity at scale.
Product Launch
Pain Point
10x Genomics is experiencing a challenging macroeconomic environment in which customer spending decisions remain constrained despite available funding, due to factors including multi-year funding allocation structures, increased grant review oversight, and staffing shortages in grant review and order processing, with no improvement anticipated in the company's current guidance assumptions.
Pain Point, Business Finance, Finance
Project
Intellectual Property, Lawsuits, Legal Affairs
Person-Based
Earnings, Capacity Planning, Finance
Open Position
10x Genomics News & Media
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidity challenge PLEASANTON, Calif., Aug. 28, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today...10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform
On August 6, 10x Genomics (NASDAQ:TXG) reported second-quarter revenue of $151 million, boosted by a $1.6 million settlement payment from Takara. Strip that out and revenue grew just 3% year-over-year to $149.4 million, a modest number next to the real headline of the quarter: a brand-new instrument platform called Atera, where booked orders have exceeded […]10x Genomics Reports Second Quarter 2026 Financial Results
PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the second quarter ended June 30, 2026. Recent Updates Revenue was $151.0...10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
Collaboration aims to identify biomarkers predictive of treatment response across multiple cancer types using 10x's single cell and spatial platforms PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding 10x Genomics
Sign Up For FreeTo access detailed company insights
Headquartered in Pleasanton, California, 10x Genomics is an American biotechnology company. The company designs and manufactures gene sequencing technology used in scientific research.... Read More
